Startup Warhound Focuses on Military K9s
Anduril is set to design protective body armor and advanced gear for the engineered canines.
Funding and Gene Editing Plans
Warhound, a new startup backed by $200 million in funding, aims to genetically engineer war dogs for the US military and equip them with specialized technology. The project brings together Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. Lamm noted that Warhound has already begun editing genes from cell samples taken from donor dogs. The startup collected samples from elite military, police, and first responder breeds, primarily Belgian Malinois, alongside select labradors and shepherds, with plans to clone them following genetic modifications.
Initial scientific efforts will concentrate on reducing susceptibility to common breed-specific health conditions such as hip dysplasia and certain cancers. Over the longer term, the company envisions potential enhancements focused on speed, agility, and olfaction.
Founders and Industry Background
Luckey previously founded Oculus VR and later formed defense contractor Anduril, which has collaborated with OpenAI and secured US Army contracts for battlefield intelligence systems. Meanwhile, Lamm's biotech firm Colossal Biosciences pursues high-profile de-extinction projects involving species such as the dire wolf and woolly mammoth.
Equipment and Leadership
While immediate plans do not involve cybernetic integration, Anduril will develop protective equipment and software, including specialized goggles, vests, and body armor. Luckey serves as a business partner without an equity stake from Anduril, whereas Colossal Biosciences holds equity with Lamm sitting on the board. David Spirk, formerly of Palantir, leads the startup as CEO.
Timeline and Deployment
Warhound anticipates the birth of its first genetically engineered dogs by early 2027. These animals are intended for standard working dog duties, including bomb detection and search-and-rescue missions.
